Reverse shoulder arthroplasty (RSA) is an increasingly common orthopedic procedure that has seen exponential growth, especially among older adults and those with rotator cuff deficiency. 5, 16 The advent of RSA has expanded our abilities to treat patients who might not have been candidates for surgery now with shoulder arthroplasty. 5, 11 Its indications for use have been expanded to include massive rotator cuff tears, inflammatory arthropathies with rotator cuff insufficiency, acute 3-and 4-part proximal humeral fractures, and primary osteoarthritis with significant bone loss. 6, 8, 11, 14, 22, 31 Many patients who may need an RSA have chronic pain, and conservative pain management has traditionally involved use of oral opioids coupled with activity modification, antiinflammatory medications, oral analgesics, corticosteroid injections, and physical therapy. 7, 23, 24, 27 The use of opioids as a first-line treatment before surgery for these patients has significant consequences leading to decreased function, decreased patient satisfaction, and increased postoperative opioid use. 17, 20, 21 In addition to the negative impact of preoperative opioid dependence, the US Centers for Disease Control and Prevention (CDC) has reported more than 115 deaths per day related to opioid abuse prescription painkiller abuse. 15 This is concerning with the current prominent overprescribing culture and the increased opioid abuse in the United States. 18, 19, 30 Currently, Americans consume up to 80% of the world's opioid supply and 99% of the world's hydrocodone supply, resulting in increased overdose rates and ever-increasing scrutiny on physician prescribing practices. 3, 25 Among all specialties, orthopedists rank first in percentage of opioids prescribed by specialty, with 61% of patients reporting
Institutional review board approval was received for this study excess opioid medication postoperatively. 3, 12, 26 Given the expanded indications for an RSA procedure and the prevailing concern regarding the culture of overprescribing, there needs to be a better understanding of how to tailor opioid-prescribing practices to reduce abuse among orthopedic patients, while adequately managing postoperative pain. 3, 15 Within orthopedics in particular, prescribing parameters do not exist. The aim of this study was to identify associations in preoperative diagnosis and opioid use patterns and risk of dependence for patients undergoing an RSA.
Methods
This study was a retrospective review of preoperative opioid use in 500 patients who underwent a primary RSA performed within a single hospital system with 10 geographic sites in 2 states between 2012 and 2016 by one of 8 fellowship-trained shoulder surgeons. Patients undergoing an RSA were identified by the use of Current Procedural Terminology code 23472. Demographic data including age, sex, race, ethnicity, body mass index, American Society of Anesthesiologists, and smoking status were collected and recorded for all patients. Preoperative diagnoses were collected based on a detailed review of preoperative surgeon notes and verified based on International Classification of DiseaseseNinth Edition diagnoses. For each patient, the orthopedic surgeon's primary assessment was recorded. Our institution's standard of care for imaging is computed tomographic scan or magnetic resonance imaging based on a patient's preoperative examination, and the results of these imaging studies were used to verify the recorded diagnosis. Patients were categorized based on preoperative diagnosis, and the top 4 most common diagnoses in patients who underwent a primary RSA were selected to include a total of 441 patients in this cohort. The top 4 preoperative diagnoses included osteoarthritis (OA) (n ¼ 129), rotator cuff tear (RCT) (n ¼ 85), rotator cuff arthropathy (RCA) (n ¼ 184), and fracture (n ¼ 69). Opioid consumption within 90 days were collected for the pre-and postoperative period using a mandated state registry (E-FORCE and OARRS). 10, 29 Patients who resided outside of Ohio or Florida were excluded from our study as we unable to reliably track prescribed narcotic medication. Total morphine equivalent (TME) was calculated as the sum of all prescriptions dispensed and compared between the groups. Opioid dependence was defined as chronic opioid use for 3 months preor postoperatively.
Statistical analyses
Continuous parameters were summarized using descriptive statistics and categorical characters summarized using numerical and percentage of cases. All doses of opioids were converted to TMEs to allow for analysis. Analysis of variance was performed to compare the means of TMEs between preoperative diagnosis groups. Independent t tests were used for continuous variables, and analyses of variance were used for comparisons of more than 2 groups. Chi-square test was performed for all categorical variables. Risk of postoperative opioid dependence was calculated using a logistic regression. Significance was considered P .05. All statistical analyses were performed using SPSS software (IBM SPSS Statistics for Macintosh, version 24.0; IBM, Armonk, NY, USA).
Results
A total of 441 patients who underwent primary RSA were included in this study. Results for baseline characteristics were significantly different between the diagnostic groups, for sex (P ¼ .0001), ethnicity (P ¼ .04), and age (P ¼ .01) ( Table I ). There were no significant differences found between the groups for race (P ¼ .067), body mass index (P ¼ .06), and American Society of Anesthesiologists class (P ¼ .27) ( Table I) . Of the whole cohort, 189 patients had a preoperative opioid prescription filled with average preoperative TMEs of 40.9 morphine milligram equivalents (MMEs) (range 5-780 MMEs). The average number of preoperative opioid prescriptions per patient was 2.41 for the cohort. Preoperative opioid use (TME) between the diagnosis groups was significantly different (P ¼ .029) (Table II) . Preoperative prescriptions for arthritis were on average 22.8 TMEs. For RCT, it was 46.12 TME; for RCA, 46.54 TME; and for fractures, 53.36 TMEs. Post hoc analysis showed that patients with osteoarthritis had the lowest average TMEs (22.82) compared with RCA (average TMEs ¼ 46.54, P ¼ .02) and fractures (TMEs ¼ 53.36, P ¼ .02), which was the highest (Table II) . Although differences in opioid use existed, there were no significant differences in preoperative opioid dependence rates according to diagnosis (P ¼ .16). RCA showed a trend toward higher opioid dependence at 40.8% compared with RCT (24.8%) and fractures (11.2%), but it was not statistically significant.
Postoperatively, the average TME for the RSA cohort overall was 148.41MMEs (range 0-2475). For OA patients, the postoperative average TME was 116.39, 196.86 for RCT, 158.43 for RCA, and 214.22 for fractures. There were no significant differences in postoperative TMEs between the groups (P ¼ .197) (Table III) . Of the whole cohort, 227 patients (50%) received more than 1 opioid prescription postoperatively, 148 patients (33%) received 3 postoperative prescriptions, and 105 patients (23.8%) received 4 or more prescriptions. Postoperatively, the OA group received an average of 85 pills in their primary prescription, compared with 83 in the RCT group, 78 in the RCA group, and 81 in the fracture group. There were no significant differences between groups (P ¼ .75). Logistic regression demonstrated that patients with preoperative opioid 
Discussion
With more than 38,329 overdose deaths in 2010 and 75% of these involving prescription pain medications, it is clear we have an opioid epidemic in the United States. 13 Several studies have described how opioids are being inadvertently overprescribed to patients postoperatively across all specialties, but it is especially pronounced within the orthopedic specialty. 13, 28 The main purpose of our study was to assess whether there were variations in opioid use based on pathology or diagnoses for 1 specific orthopedic surgical procedure. This information is critical for orthopedic surgeons in awareness and risk stratification as there is a tendency to use standardized postoperative opioid-prescribing patterns for specific procedures. Recent studies by Shrank et al 28 and Rodgers et al 25 found that most patients did not take opioid medications as prescribed, and furthermore, most did not finish their prescriptions as they were either no longer in pain or because they experienced adverse side effects. Overprescribing has meant that much of the unused medication has been stockpiled by patients who are often not educated on safe disposal, leaving unused pills open to diversion and alternate use. 25 The difference in preoperative usage and dependence rates for different pathologies highlights the need for surgeons to be aware of patient pathology and diagnosis when planning for postoperative pain management for any specific procedure such as RSA. Clearly, a one-size-fits-all approach in postoperative pain management may not be optimal given the increased risks of preoperative exposure to and dependence on opioids depending on various diagnoses. Based on our results, patients undergoing RSA for RCA may be at the highest risk for postoperative opioid dependence. Perhaps we should limit postoperative prescriptions for these patients given recent studies among orthopedic trauma patients that found the opioid quantity dispensed at discharge after surgery is predictive of opioid use postoperatively. 2, 9 The difference in opioid dependence rates is also important to note in that despite getting the same surgery, patients with preoperative OA require significantly less opioids than those with RCA. Despite both these conditions being chronic pathologies, there seems to be increased pain with muscle injury. This is contrary to current findings which suggest that soft tissue surgery patients consumed less opioid medications. 25 It has also been reported that preoperative opioid use is highly correlated with postoperative use among patients undergoing joint arthroplasty. 1, 4, 32 Among a population of patients who underwent shoulder arthroplasty, we found that preoperative opioid use increased the risk of postoperative opioid use and dependence. This is in concurrence with the hip and knee arthroplasty literature as well as those patients undergoing arthroscopic repairs. 1, 4, 7, 9 It was also found that postoperative opioid use in these preoperative opioid-dependent patients continued even at 1-year follow-up (mean final follow-up of 47.1 months), indicating that patients who are opioid-dependent before shoulder arthroplasty remain chronically opioid-dependent even following surgery. 4 Perhaps implementing a weaning program for these preoperative dependent patients may more successfully get them off opioids postoperatively and decrease long-term dependence. In addition, our study has demonstrated that preoperatively dependent patients had an 8 times higher risk of postoperative dependence after RSA. Integrating a preoperative risk assessment that includes diagnosis may be important to plan for effective pain management following RSA in the future while helping to curb postoperative dependence. Recently, there has been focus on integrating multimodal pain protocols with acetaminophen, gabapentin, and liposomal bupivacaine to curb postoperative opioid dependence, and these have been found to have some success, but the literature has not reached a consensus on optimizing these types of medications. Future studies are needed to assess the efficacy of these types of protocols in reducing or eliminating the need for opioids based on different diagnoses. Although we can draw some important conclusions from this study, it is not without limitations. This was a database study based on prescriptions recorded from state databases and not actual patient consumption patterns. In addition, we did not take into account other diagnoses that may have led to preoperative opioid dependence, and these comorbidities and pain generators were not available. Because this was a retrospective review, there was no outcome data recorded to correlate each diagnosis with effects of opioid use and dependence on outcomes. Future studies should focus on stratifying opioid use and dependence with impact on patient-reported and functional outcomes following shoulder arthroplasty. In 
Conclusions
Our study demonstrated that patients diagnosed with a fracture before undergoing RSA consume the highest amounts of opioids both pre-and postoperatively compared with other preoperative diagnoses; however, RCA patients had the highest dependence rates. Surgeons should tailor their preoperative education and postoperative pain management protocols accordingly, based on specific diagnoses for RSA. In addition, steps should be taken to increase awareness and improved pain protocols ought to be implemented for preoperative opioid-dependent patients, as they are 8 times more likely to remain opioid-dependent postoperatively.
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